On August 13th, Northeast Pharmaceutical Group briefly hit the limit down, with Hunan Er-Kang Pharmaceutical, Minsheng Health, Zhejiang Shengda Bio-Pharm and Guangdong Zhongsheng Pharmaceutical following the decline.
A股维生素板块持续走低 东北制药触及跌停
A-share vitamins sector continues to decline, Northeast Pharmaceutical Group hits the limit down.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.